About Micron Biomedical
Micron Biomedical is a private company based in Atlanta, Georgia. It has reported $32,014,469 raised in three offerings on Form D since December 2022. Its chief executive is Steve Damon.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Dec 11, 2024 | Dec 26, 2024 | $14,999,983of $16.2M target | 3 | $4.9M | EquityRule 506(b) | Form D ↗ |
| Apr 4, 2023 | Apr 17, 2023 | $2,999,995fully sold | 1 | $2.9M | EquityRule 506(b) | Form D ↗ |
| Nov 22, 2022 | Dec 7, 2022 | $14,014,491fully sold | 4 | $3.5M | EquityRule 506(b) | Form D ↗ |
| Total, three offerings | $32,014,469 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Micron Biomedical's Form D filed Dec 26, 2024.
MP
Mark Prausnitz
Director
HS
Henry Sebastien
Executive Vice President, Head of Technical Operations
DM
Devin McAllister
Executive Vice President, Chief Technology Officer
IM
Idean Marvasty
Chief Financial Officer
BB
Brian Bernick
Director
BB
Bas Van Buijtenen
Director
SD
Steve Damon
Chief Executive Officer and director
MG
Matthew Goldman
Director
LA
Labeeb Abboud
Director